CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to enhance drug delivery systems by developing lipid nanoparticles that combine therapeutic and imaging functions. It focuses on improving cellular uptake and gene release through tailored fluorination, enabling non-invasive tracking of drug nanocarriers in vivo.
The formulation of drug nanocarriers has attracted increasing attention over the last decades.
In particular, the possibility to combinetherapeutic and imaging functionalities in a single nanoplatform (theranostic) has been widely explored to advance therapeuticapproaches and promote the transition from conventional medicine to personalized medicine.Drug nanocarriers, holding the potential to produce a revolution in medicine, are lipid nanoparticles (LNPs) for gene delivery.
Theyhave proven vers…
POLITECNICO DI MILANO
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Sweden, Sodertaelje
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
